Melanoma and Skin Cancer Trials Limited (MASC Trials) is Australia and New Zealand’s collaborative clinical trials group committed to improving melanoma and skin cancer outcomes.

Working with leading researchers, MASC Trials conducts multicentre, national and international clinical trials at more than 110 institutions in Australia and overseas. Our diverse and growing portfolio includes research in the prevention, early detection and treatment of melanoma and skin cancer, including early to late phase clinical trials.

Our 2,250+ members throughout Australia and around the world represent the many disciplines critical to our work and strengthen the success of our clinical trials. Together, we work to reduce the burden of melanoma and skin cancer on the healthcare system.

From early engagement with consumers and researchers to develop research ideas, through to the publication of results, we work cooperatively to provide a range of clinical trial services. We value the experiences of consumers and our
collaborative approach ensures their unique perspectives are considered in clinical trial prioritisation and development.

MASC Trials continues to be supported by the Australian Government via Cancer Australia, Monash University and the generosity of our corporate partners and donors.

The high-quality evidence published from our trials changes clinical practice to impact the lives of patients and improve how doctors prevent, diagnose and treat melanoma and skin cancer.

MASC Trials Ltd is registered as a charity with the Australian Charity and Not-for Profits Commission. 

Biotechnology

Clinical Trials

Health Care

Life Sciences

Melanoma and Skin Cancer Trials

Melanoma and Skin Cancer Trials' headquarters in Melbourne, Australia

Description

People (1)

Paul White

Jobs